Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk.

Monsees GM, Kraft P, Chanock SJ, Hunter DJ, Han J.

Breast Cancer Res Treat. 2011 Jan;125(1):207-14. doi: 10.1007/s10549-010-0947-3. Epub 2010 May 23.

2.

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.

Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC, Berg CD, Buring JE, Chanock SJ, Diver WR, Dostal L, Fournier A, Hankinson SE, Henderson BE, Hoover RN, Isaacs C, Johansson M, Kolonel LN, Kraft P, Lee IM, McCarty CA, Overvad K, Panico S, Peeters PH, Riboli E, Sanchez MJ, Schumacher FR, Skeie G, Stram DO, Thun MJ, Trichopoulos D, Zhang S, Ziegler RG, Hunter DJ, Lindström S, Canzian F.

J Natl Cancer Inst. 2011 Aug 17;103(16):1252-63. doi: 10.1093/jnci/djr265. Epub 2011 Jul 26.

3.

Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.

Slattery ML, Baumgartner KB, Giuliano AR, Byers T, Herrick JS, Wolff RK.

Breast Cancer Res Treat. 2011 Sep;129(2):531-9. doi: 10.1007/s10549-011-1498-y. Epub 2011 Apr 8.

4.

Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.

Fu YP, Yu JC, Cheng TC, Lou MA, Hsu GC, Wu CY, Chen ST, Wu HS, Wu PE, Shen CY.

Cancer Res. 2003 May 15;63(10):2440-6.

5.

Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk.

Han J, Haiman C, Niu T, Guo Q, Cox DG, Willett WC, Hankinson SE, Hunter DJ.

Breast Cancer Res Treat. 2009 Jun;115(3):613-22. doi: 10.1007/s10549-008-0089-z. Epub 2008 Jun 13.

6.

Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk.

Han J, Hankinson SE, Zhang SM, De Vivo I, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):520-4.

7.

Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.

Hsu HM, Wang HC, Chen ST, Hsu GC, Shen CY, Yu JC.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2024-32.

8.

Comprehensive association testing of common genetic variation in DNA repair pathway genes in relationship with breast cancer risk in multiple populations.

Haiman CA, Hsu C, de Bakker PI, Frasco M, Sheng X, Van Den Berg D, Casagrande JT, Kolonel LN, Le Marchand L, Hankinson SE, Han J, Dunning AM, Pooley KA, Freedman ML, Hunter DJ, Wu AH, Stram DO, Henderson BE.

Hum Mol Genet. 2008 Mar 15;17(6):825-34. Epub 2007 Dec 3.

9.

Variants in DNA double-strand break repair genes and breast cancer susceptibility.

Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, Day NE, Easton DF, Ponder BA, Pharoah PD, Dunning A.

Hum Mol Genet. 2002 Jun 1;11(12):1399-407.

10.

Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.

Mealiffe ME, Stokowski RP, Rhees BK, Prentice RL, Pettinger M, Hinds DA.

J Natl Cancer Inst. 2010 Nov 3;102(21):1618-27. doi: 10.1093/jnci/djq388. Epub 2010 Oct 18.

11.

Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population.

Liang J, Chen P, Hu Z, Shen H, Wang F, Chen L, Li M, Tang J, Wang H, Shen H.

Breast Cancer Res Treat. 2010 Nov;124(1):237-41. doi: 10.1007/s10549-010-0809-z. Epub 2010 Mar 9.

PMID:
20213080
12.

Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.

Milne RL, Benítez J, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Arias JI, Zamora MP, Burwinkel B, Bartram CR, Meindl A, Schmutzler RK, Cox A, Brock I, Elliott G, Reed MW, Southey MC, Smith L, Spurdle AB, Hopper JL, Couch FJ, Olson JE, Wang X, Fredericksen Z, Schürmann P, Bremer M, Hillemanns P, Dörk T, Devilee P, van Asperen CJ, Tollenaar RA, Seynaeve C, Hall P, Czene K, Liu J, Li Y, Ahmed S, Dunning AM, Maranian M, Pharoah PD, Chenevix-Trench G, Beesley J; kConFab Investigators; AOCS Group, Bogdanova NV, Antonenkova NN, Zalutsky IV, Anton-Culver H, Ziogas A, Brauch H, Justenhoven C, Ko YD, Haas S, Fasching PA, Strick R, Ekici AB, Beckmann MW, Giles GG, Severi G, Baglietto L, English DR, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Turnbull C, Hines S, Renwick A, Rahman N, Nordestgaard BG, Bojesen SE, Flyger H, Kang D, Yoo KY, Noh DY, Mannermaa A, Kataja V, Kosma VM, García-Closas M, Chanock S, Lissowska J, Brinton LA, Chang-Claude J, Wang-Gohrke S, Shen CY, Wang HC, Yu JC, Chen ST, Bermisheva M, Nikolaeva T, Khusnutdinova E, Humphreys MK, Morrison J, Platte R, Easton DF; Breast Cancer Association Consortium.

J Natl Cancer Inst. 2009 Jul 15;101(14):1012-8. doi: 10.1093/jnci/djp167. Epub 2009 Jun 30.

13.

Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer.

Zhang Y, Newcomb PA, Egan KM, Titus-Ernstoff L, Chanock S, Welch R, Brinton LA, Lissowska J, Bardin-Mikolajczak A, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M.

Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):353-8.

14.

Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk.

Lee KM, Choi JY, Kang C, Kang CP, Park SK, Cho H, Cho DY, Yoo KY, Noh DY, Ahn SH, Park CG, Wei Q, Kang D.

Clin Cancer Res. 2005 Jun 15;11(12):4620-6.

15.

Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women.

Boone SD, Baumgartner KB, Baumgartner RN, Connor AE, Pinkston CM, John EM, Hines LM, Stern MC, Giuliano AR, Torres-Mejia G, Brock GN, Groves FD, Kerber RA, Wolff RK, Slattery ML.

Breast Cancer Res Treat. 2013 Sep;141(2):287-97. doi: 10.1007/s10549-013-2690-z. Epub 2013 Sep 14.

16.

Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population.

Kim KY, Han W, Noh DY, Kang D, Kwack K.

Gene. 2013 Dec 15;532(2):192-6. doi: 10.1016/j.gene.2013.09.069. Epub 2013 Sep 25.

PMID:
24076439
17.

Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.

Low YL, Li Y, Humphreys K, Thalamuthu A, Li Y, Darabi H, Wedrén S, Bonnard C, Czene K, Iles MM, Heikkinen T, Aittomäki K, Blomqvist C, Nevanlinna H, Hall P, Liu ET, Liu J.

PLoS Genet. 2010 Jul 1;6(7):e1001012. doi: 10.1371/journal.pgen.1001012.

18.

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

19.

Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study.

Han J, Hankinson SE, Ranu H, De Vivo I, Hunter DJ.

Carcinogenesis. 2004 Feb;25(2):189-95. Epub 2003 Oct 24.

20.

A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.

Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1462-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk